Discontinuation of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Chronic Kidney Disease-Reference-Cited by-同舟云学术

Discontinuation of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Chronic Kidney Disease

Published:2019-11 Issue:11 Volume:94 Page:2220-2229
ISSN:0025-6196
Container-title:Mayo Clinic Proceedings
language:en
Short-container-title:Mayo Clinic Proceedings

Author:

Qiao Yao^ORCID,Shin Jung-Im,Sang Yingying,Inker Lesley A.,Secora Alex,Luo Shengyuan,Coresh Josef,Alexander G. Caleb,Jackson John W.,Chang Alex R.,Grams Morgan E.^ORCID

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

General Medicine

Reference29 articles.

1. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults

2. A random comparison of fosinopril and nifedipine GITS in patients with primary renal disease;Marin;J Hypertens,2001

3. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes;Lewis;N Engl J Med,2001

4. The effect of angiotensin-converting enzyme inhibitor/angiotensin receptor blocker use on mortality in patients with chronic kidney disease: a meta-analysis of observational studies;Qin;Pharmacoepidemiol Drug Saf,2016

5. Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial;Agodoa;JAMA,2001

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Outcomes in Patients with CKD and Rapid or Non-rapid eGFR Decline: A Report from the DISCOVER CKD Retrospective Cohort;Advances in Therapy;2024-07-03

2. Estimated Effect of Restarting Renin-Angiotensin System Inhibitors after Discontinuation on Kidney Outcomes and Mortality;Journal of the American Society of Nephrology;2024-06-18

3. Type 2 Diabetes and Chronic Kidney Disease: An Opportunity for Pharmacists to Improve Outcomes;Journal of Clinical Medicine;2024-02-28

4. Mortality and hyperkalaemia-associated hospitalisation in patients with chronic kidney disease: comparison of sodium zirconium cyclosilicate and sodium/calcium polystyrene sulfonate;Clinical Kidney Journal;2024-02-01

5. Risk of hyperkalaemia in patients with type 2 diabetes mellitus prescribed with SGLT2 versus DPP-4 inhibitors;European Heart Journal - Cardiovascular Pharmacotherapy;2023-11-06